Activity
Everything else — drafts, in review, posted and skipped. Nothing is deleted.
- no image#1Draft
The outbound agent is called Hunter
Salesforce's outbound agent is called Hunter. It's built to work your pipeline for months, not minutes.
Last touched
week of 21 September 2026
- no image#2Draft
Positioning that survives a summary
Ask an assistant what your company does. That paragraph is your positioning now — not the one on your site.
Last touched
week of 21 September 2026
- no image#3Draft
The supplier list you never wrote down
Four of the most-used AI coding agents trusted a pin that could lie. The pin looked intact the whole time.
Last touched
week of 21 September 2026
- no image#4Draft
They price against last month
Anthropic raised a limit by 25% and had to call it a 17% cut. Both were true.
Last touched
week of 21 September 2026
- no image#1Draft
AI search stopped being one channel
A year ago ChatGPT was about three-quarters of gen-AI traffic. By August it was closer to half.
Last touched
week of 14 September 2026
- no image#2Draft
Accuracy is the new courtesy
Research got free. Being wrong about someone got expensive.
Last touched
week of 14 September 2026
- no image#3Draft
The ceiling on what performance is worth
More businesses are buying AI than ever, and spending less per head on it. Both are true.
Last touched
week of 14 September 2026
- no image#4Draft
The first thing AI kills is the status meeting
The first thing AI removes from a small company isn't a role. It's the status meeting.
Last touched
week of 14 September 2026
- no image#1Draft
The shadow use case ships with the product
OpenAI shipped its most capable model last week, then put $1bn behind defending water utilities from it.
Last touched
week of 7 September 2026
- no image#2Draft
They already asked the model about you
Your buyer asked an AI what's wrong with your product before they ever spoke to you.
Last touched
week of 7 September 2026
- no image#3Draft
Your copy now carries a signature
AI-written text has started carrying an invisible signature, and regulators got the reader before you did.
Last touched
week of 7 September 2026
#4PublishedThe next hire got more expensive
AI didn't make your next hire cheaper. It made them more expensive — and you should pay it.
Posted
week of 7 September 2026
#1PublishedSalesforce made itself a plugin
Last week the world's biggest CRM shipped itself as a plugin inside somebody else's chat window.
Posted
week of 31 August 2026
- no image#2Draft
Verification is the bottleneck
Generation is free. Checking is not. That's your whole constraint now.
Last touched
week of 31 August 2026
#3PublishedAverage is a position
Half of marketers say AI made their work faster and more average. Average is a position, not a setting.
Posted
week of 31 August 2026
- no image#4Draft
Speed stopped being the edge
Every vendor now replies in sixty seconds. Speed stopped being a differentiator the day it got automated.
Last touched
week of 31 August 2026
#1PublishedThe ladder that stopped going up
Stanford just measured the effects on career ladders when Ai gets good enough to compete.
Posted
week of 24 August 2026
- no image#2Draft
The perfect CRM nobody reads
Your CRM has never been more complete. It has never been less useful.
Last touched
week of 24 August 2026
- no image#3Draft
LinkedIn removed its own AI writing button
LinkedIn deleted its 'write with AI' button and gave everyone else a button to report you.
Last touched
week of 24 August 2026
- no image#4Draft
Write the twenty examples first
Before you write the prompt, write twenty examples of the correct answer.
Last touched
week of 24 August 2026
- no image#1Draft
Publish the price
Four years running, B2B buyers have asked vendors for the same thing. Most still refuse.
Last touched
week of 17 August 2026
- no image#2Draft
A full calendar stopped being a signal
AI didn't fix your pipeline. It filled it with people who were never going to buy.
Last touched
week of 17 August 2026
- no image#3Draft
The gain was in what they deleted
Cloudflare shipped a browser with no tabs, no themes and no pixel-perfect rendering. It's up to 7× cheaper to run.
Last touched
week of 17 August 2026
- no image#1Draft
The click is no longer the prize
68% of Google searches in the US now end without a single click. Your funnel starts later than you think.
Last touched
week of 10 August 2026
- no image#2Draft
Personalisation stopped signalling anything
The 'personalised' cold email is dead — because it finally worked at scale.
Last touched
week of 10 August 2026
- no image#3Draft
Changelogs as org charts
Stop reading AI vendors' homepages. Read their changelogs — that's where the truth ships.
Last touched
week of 10 August 2026
- no image#1Draft
The launch plan nobody puts on the Gantt chart
Everyone in market access says "get payers involved early." After a dozen GI launches, I think that's only half the advice — and the half nobody checks is the one that sinks products.
Last touched
week of 3 August 2026
- no image#2Draftcarousel
Where AI actually helps in pharma commercial (and where it's still hype)
I've sat through more "AI will transform pharma" pitches than I can count. Maybe 20% of them survive contact with a real commercial team. Here's the framework I use to tell which is which.
Last touched
week of 3 August 2026
#3PublishedThe hydration myth we keep repeating
This weekend I noticed something subtle....
Posted
week of 3 August 2026
- no image#4Draft
Four generations, four different paths to the same health decision
Boomers Google their symptoms. Gen Z asks TikTok. Same health question, completely different buying journey — and most health brands still market to only one of them.
Last touched
week of 3 August 2026
#1SkippedAccess isn't the last hurdle — it's the starting line
The best launch plan I saw this year had almost nothing to do with the drug.
Last touched
week of 27 July 2026
#2Skippedcarousellast send failed6 questions to ask before you fund another AI pilot
Most "AI in pharma" pilots quietly die in month four. Here's the pattern I keep seeing.
Last touched
week of 27 July 2026
- no image#3Skipped
Three myths about commercialising rare & GI medicines
"Rare disease means small commercial thinking." That myth costs patients years.
Last touched
week of 27 July 2026
- #4Skipped
One health message, four definitions of "trust"
A Boomer and a Gen Z shopper can buy the same supplement for completely opposite reasons.
Last touched
week of 27 July 2026